OmniAb Inc. (OABIW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in OmniAb Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

OmniAb Inc. (OABIW) has returned -33.28% so far this year and -78.56% over the past 12 months.

Based on dividend-adjusted daily data since Sep 30, 2021, OABIW's average daily return is +0.27%, while the average monthly return is +0.27%. At this rate, your investment would double in approximately 21.4 years.

Historically, 37% of months were positive and 63% were negative. The best month was Dec 2023 with a return of +77.6%, while the worst month was Nov 2022 at -47.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, OABIW closed higher 28% of trading days. The best single day was Mar 24, 2022 with a return of +96.5%, while the worst single day was Nov 2, 2022 at -49.5%.

OmniAb Inc. has an annualized alpha of 87.77%, beta of 0.41, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 01, 2021.

• This stock participated in 180.01% of S&P 500 Index downside but only -5.35% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.41 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OABIW ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for OmniAb Inc. (OABIW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the OmniAb Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the OmniAb Inc. was 94.91%, occurring on Jan 15, 2026. The portfolio has not yet recovered.

The current OmniAb Inc. drawdown is 94.58%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of OmniAb Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how OmniAb Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.